The USPTO granted Apple a new patent last week that details ways the iPhone itself could be used as a health sensor to detect "blood pressure index, blood hydration, body fat content, oxygen saturation, pulse rate, perfusion index, electrocardiogram, photoplethysmogram, and/or any other such health data." This data could be gleaned from the front-facing camera, the ambient light sensor, the...
The AliveCor Heart Monitor can be a cost-effective method to identify high risk of stroke in adults over 65 years old, according to a recent feasibility study published in the journal Thrombosis and Haemostasis.
AliveCor's heart monitor is available in the form of a smartphone case or a peripheral that attaches to the back of the phone. It sends data to a companion app that stores the device's...
Researchers in Australia presented findings this month on the accuracy and benefits of the mobile health device developed by Khosla Ventures-backed US company AliveCor. The iPhone-enabled AliveCor Heart Monitor, formerly called the iPhone ECG, captures ECG from a special case that fits the patient or physician's smartphone. While the device's inventor American cardiologist Dr. Dave Albert is well...
Cardiac Designs' FDA-cleared ECG Check, not yet commercially available.
A new ECG device for the iPhone 4s called ECG Check received over-the-counter clearance from the FDA last month. The device, which would be the first product from Park City, Utah-based Cardiac Designs, appears very similar to the AliveCor Heart Monitor, which is currently only cleared for prescription use. The device was...
AliveCor, originator of the widely praised iPhone ECG, is going to the dogs – and cats and horses.
San Francisco-based AliveCor, founded by Oklahoma City cardiologist and entrepreneur Dr. David Albert, as of this month is marketing an iPhone-based veterinary heart monitor to veterinary health professionals and pet owners. In fact, since the human product has not received Food and Drug...
AliveCor's iPhoneECG device, which was the talk of CES in 2011, is close to securing a CE Mark, paving the way for the device to roll out commercially in Europe. At least one speaker at the HIMSS event last week and at least one report coming out of the Burrill Digital Health Meeting earlier this month, claimed that the iPhone ECG's CE Mark was already secured. AliveCor founder Dr. David Albert...
By 2016 the number of patients monitored over mobile networks will hit 3 million, according to Juniper Research. The firm believes that increasing smartphone processing power along with new healthcare peripherals will cause an uptick in more patients using the smartphone as a home health hub. That shift will also lower the cost of remote patient monitoring since it will reduce the need for costly...
Apple's iPhone has been widely praised for its elegant design. Similarly, the much-heralded iPhone ECG from Dr. David Albert's AliveCor is simplistic in its form, easily bolting on to the back of the iconic smartphone.
A competing offering from Canadian mobile medical products developer Yoritex seems more diverse in its potential uses. But it appears to be clunkier when it comes to design,...
The future of mHealth is bright, according to West Wireless Health Institute vice chairman Eric Topol, who spoke this week at the opening keynote of the 2011 mHealth Summit. "This is a most momentous moment in medicine," he told the gathered audience. Topol's keynote discussion included current wireless medical products as well as future speculation that will leverage genomics with biosensor data...
AliveCor, developer of the iPhone ECG, announced this week that it has raised $3 million in its first round of funding. The investment was funded by Burrill & Company, Qualcomm Ventures and the Oklahoma Life Sciences Fund.
The company plans to use the investment to expand its team, gain regulatory approval and market the device worldwide. AliveCor expects to commercially launch its iPhone...
